单核细胞中的组蛋白甲基转移酶MLL1/KMT2A驱动冠状病毒相关凝血病和炎症
本研究利用鼠β冠状病毒MHVA59模型发现,组蛋白甲基转移酶MLL1/KMT2A调控单核/巨噬细胞促凝和促纤溶因子表达,并促进炎症、抑制IFN-α;在SARS-CoV-2阳性人样本中,CD14+单核/巨噬细胞MLL1及凝血病相关因子表达和活性上调,血浆PLAU和TF活性升高。
要点
- MLL1调控单核/巨噬细胞促凝和促纤溶因子(F3、PLAU、PLAUR)表达。
- MLL1促进促炎细胞因子表达并抑制IFN-α表达。
核心结论
- 单核/巨噬细胞MLL1在促进冠状病毒相关凝血病和炎症中起重要作用。
研究设计与样本
- 使用鼠β冠状病毒MHVA59作为SARS-CoV-2感染实验模型,并在体外模型和SARS-CoV-2阳性人样本中进行验证分析。
主要发现
- 在未感染和感染细胞中,MLL1调控单核/巨噬细胞促凝和促纤溶因子F3、PLAU和PLAUR的表达。
- MLL1同时促进促炎细胞因子表达并抑制IFN-α表达。
- 体外模型显示MLL1依赖的NF-κB/RelA介导这些凝血相关因子的转录,体内RelA作用呈背景依赖且不依赖MLL1。
- 冠状病毒感染后体内炎症、促凝和促纤溶表型为MLL1依赖,尽管MO/Mφs中Ifna诱导减弱。
- SARS-CoV-2阳性人样本中,CD14+ MO/Mφs的MLL1及凝血病相关因子表达和活性相对未感染和健康对照差异上调,血浆PLAU和TF活性升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus-associated coagulopathy (CAC) is a morbid and lethal sequela of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. CAC results from a perturbed balance between coagulation and fibrinolysis and occurs in conjunction with exaggerated activation of monocytes/macrophages (MO/Mφs), and the mechanisms that collectively govern this phenotype seen in CAC remain unclear. Here, using experimental models that use the murine betacoronavirus MHVA59, a well-established model of SARS-CoV-2 infection, we identify that the histone methyltransferase mixed lineage leukemia 1 (MLL1/KMT2A) is an important regulator of MO/Mφ expression of procoagulant and profibrinolytic factors such as tissue factor (F3; TF), urokinase (PLAU), and urokinase receptor (PLAUR) (herein, "coagulopathy-related factors") in noninfected and infected cells. We show that MLL1 concurrently promotes the expression of the proinflammatory cytokines while suppressing the expression of interferon alfa (IFN-α), a well-known inducer of TF and PLAUR. Using in vitro models, we identify MLL1-dependent NF-κB/RelA-mediated transcription of these coagulation-related factors and identify a context-dependent, MLL1-independent role for RelA in the expression of these factors in vivo. As functional correlates for these findings, we demonstrate that the inflammatory, procoagulant, and profibrinolytic phenotypes seen in vivo after coronavirus infection were MLL1-dependent despite blunted Ifna induction in MO/Mφs. Finally, in an analysis of SARS-CoV-2 positive human samples, we identify differential upregulation of MLL1 and coagulopathy-related factor expression and activity in CD14+ MO/Mφs relative to noninfected and healthy controls. We also observed elevated plasma PLAU and TF activity in COVID-positive samples. Collectively, these findings highlight an important role for MO/Mφ MLL1 in promoting CAC and inflammation.
引用
- Sharma SB, Melvin WJ, Audu CO, et al. The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood. 2023. PMID: 36493338. doi:10.1182/blood.2022015917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。